Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
64
NCT02534480
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2015
Completion: Nov 30, 2015
NCT02537938
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
Start: Jan 31, 2016
Completion: Dec 31, 2016